Use of Prolonged-Infusion Beta-Lactam Antibiotics

Publication Date: August 24, 2023
Last Updated: September 1, 2023

Summary of Recommendations

Preclinical targets for reductions in CFU are 40%–70% fT>MIC for SI and up to 4-h EI, and 100% fT>MIC with concentrations that exceed up to four to eight times free drug over the steady-state concentration (fCss) for CI. No absolute target guarantees suppression of resistance but exceeding the MIC by four to six times may minimize resistance. (U, U)
620

Overview

Title

Use of Prolonged-Infusion Beta-Lactam Antibiotics

Authoring Organizations